HuGE Literature Finder
Records 1-6
|
Correlation Between Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphisms and Pemetrexed Chemotherapy Efficacy/Toxicity in Non-Squamous Non-Small Cell Lung Cancer.
Medical science monitor : international medical journal of experimental and clinical research 2017 Nov 23 5683-5689. Lan Gaochen, Lin Lin, Chen Xiong, Chen Libin, Chen |
|
Angiotensin converting enzyme and methylenetetrahydrofolate reductase gene variations in fibromyalgia syndrome.
Gene 2015 Jun 564 (2): 188-92. Inanir Ahmet, Yigit Serbulent, Tekcan Akin, Pinarli Ferda Alpaslan, Inanir Sema, Karakus Nev |
|
Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue.
Cellular and molecular neurobiology 2013 Nov 33 (8): 1055-63. Bahadir Anzel, Eroz Recep, Dikici Sub |
|
Pharmacogenomic assessment of outcomes of pemetrexed-treated patients with adenocarcinoma of the lung.
Yonsei medical journal 2013 Jul 54 (4): 854-64. Jung Minkyu, Lee Chul Ho, Park Hyung Soon, Lee Ji Hyun, Kang Young Ae, Kim Se Kyu, Chang Joon, Kim Dae Joon, Rha Sun Young, Kim Joo Hang, Cho Byoung Ch |
|
Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.
Cancer 2006 Mar 106 (5): 1007-16. Massacesi Cristian, Terrazzino Salvatore, Marcucci Fabiana, Rocchi Marco B, Lippe Paolo, Bisonni Renato, Lombardo Marco, Pilone Alberta, Mattioli Rodolfo, Leon Alber |
|
Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Jul 22 (14_suppl): 5. Sloan J A, McLeod H, Sargent D, Zhao X, Fuchs C, Ramanathan R, Williamson S, Findlay B, Morton R, Goldberg R |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 27, 2020
- Content source: